Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial Carcinoma
Clinical trial NCT04871334 · UNKNOWN
Trial details
- NCT number
- NCT04871334
- Sponsor
- Shandong TheraWisdom Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-07
- Primary completion
- 2022-10-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.